Reprogenesis


Public lists: Pharma Startups (6570)

Reprogenesis is a therapeutic drug development company, focusing on regulatory pathways that control repair and regeneration using proteins or small molecules to modulate these pathways.

Reprogenesis is a therapeutic drug development company, focusing on regulatory pathways that control repair and regeneration using proteins or small molecules to modulate these pathways.

Company (Alive / Active)

Phone: 617-503-6500

Fax:

45 Moulton Street

Cambridge, 02138
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Reprogenesis $48.1M Oct 18, 2004
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Reprogenesis Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 36 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

NeuroGenomeX

Madison, Wisconsin, United States
Alive / ActiveNeuroGenomeX is a drug discovery company developing novel treatments for diseases of the brain and nervous system. The current NeuroGenomeX discovery program is focused on therapeutic target areas of epilepsy and traumatic brain injury. NeuroGenomeX is advancing its lead drug candidate, 2-deoxy-D-glucose (2DG), as an anticonvulsant that stops seizures and has beneficial effects against adverse long-term consequences of epilepsy. 2DG also has shown favorable therapeutic neuroprotective effects in...Show allLogin to see details

eSionic

Menlo Park, California, United States
Alive / ActiveeSionic, formerly Zettacore, enables devices and systems that consume less materials, generate less waste, have longer life, operate with higher reliability, use less energy, integrate seamlessly, operate more efficiently and cost less.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)